Saatchis fights to keep Xian Janssen brands
Johnson & Johnson JV Xian Janssen is reviewing its creative accounts for its Daktarin and Pevisone brands, with at least four agencies believed to be in the running. The combined value of the business is estimated at Rmb 100 million (US$15 million).
Please sign in below or access limited articles a month after free, fast registration.
If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.
Sign In
Register for free
✓ Access limited free articles each month
✓ Email bulletins – top industry news and insights delivered straight to your inbox
Subscribe
✓ Unlimited access to all Campaign Asia content
✓ Real-world campaign case studies and career insights
✓ Exclusive reports, industry news, and annual features